2013
DOI: 10.1083/jcb.201303044
|View full text |Cite
|
Sign up to set email alerts
|

CCM1–ICAP-1 complex controls β1 integrin–dependent endothelial contractility and fibronectin remodeling

Abstract: Loss of CCM1/2 leads to destabilization of ICAP-1 and up-regulation of β1 integrin, resulting in the destabilization of intercellular junctions due to increased cell contractility and aberrant extracellular matrix remodeling.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

12
161
2
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 94 publications
(176 citation statements)
references
References 82 publications
(155 reference statements)
12
161
2
1
Order By: Relevance
“…ICAP-1 (also known as ITGB1BP1), a negative regulator of β1 integrin, enables the cell to sense ECM density to adapt its adhesive and migratory responses (Millon-Frémillon et al, 2008) and to control fibronectin (FN) remodeling (Brunner et al, 2011;Faurobert et al, 2013). ICAP-1 specifically binds to the cytoplasmic tail of β1 integrin, maintaining the integrin in its inactivated form by competing with the two activators named Kindlin and talin (Brunner et al, 2011;Millon-Frémillon et al, 2008;Montanez et al, 2008;Ye et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…ICAP-1 (also known as ITGB1BP1), a negative regulator of β1 integrin, enables the cell to sense ECM density to adapt its adhesive and migratory responses (Millon-Frémillon et al, 2008) and to control fibronectin (FN) remodeling (Brunner et al, 2011;Faurobert et al, 2013). ICAP-1 specifically binds to the cytoplasmic tail of β1 integrin, maintaining the integrin in its inactivated form by competing with the two activators named Kindlin and talin (Brunner et al, 2011;Millon-Frémillon et al, 2008;Montanez et al, 2008;Ye et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to its role in the β1 integrin activation cycle (MillonFrémillon et al, 2008), ICAP-1 interferes with small GTPase signaling and cell contractility by putting a cap on RhoA activation (Faurobert et al, 2013) and inhibiting Rac1 and Cdc42 (Degani et al, 2002). So far, how ICAP-1 can regulate both RhoA-ROCK signaling and the Cdc42 and Rac1 pathway was unclear.…”
mentioning
confidence: 99%
“…It is possible that, following the loss of the synergy site, integrins are actively transitioned into a closed inactive conformation and trafficked out of adhesion sites through the action of negative regulators of integrin activation, such as sharpin, filamin or ICAP1 (also known as ITGB1BP1). Interestingly, ICAP1-mediated regulation of b1 integrin activation has recently been linked to both aberrant vasculogenesis and ECM remodeling (Faurobert et al, 2013). Our data suggest that, following anastellin treatment, the avb5 integrins function to maintain adhesion as well as the activation of integrin-associated signaling proteins, whereas a5b1-specific functions are selectively inhibited.…”
Section: Discussionmentioning
confidence: 52%
“…For example, Cdk5 is required cellautonomously in both (Hirasawa et al, 2004;Ohshima et al, 2007), Dab1 is required only in migrating neurons (Franco et al, 2011), whereas β1 integrins (Belvindrah et al, 2007) and RhoA (Cappello et al, 2012) are radial glia specific. Ccm3 (this study) and Itgb1 mutants display neuronal migration and cortical lamination defects (Graus-Porta et al, 2001;Schmid et al, 2004;Huang et al, 2006;Marchetti et al, 2010), pial detachment of endfeet (Graus-Porta et al, 2001;Kwon et al, 2011) and reactive gliosis (Robel et al, 2009), suggesting a -possibly indirectinteraction that warrants investigation, especially given the association of CCM1 with ICAP1α, which binds the β1 integrin cytoplasmic tail (Zawistowski et al, 2002;Faurobert et al, 2013). On the other hand, RhoA is necessary in radial glia to stabilize the actin and microtubule cytoskeletons, and to maintain the radial glia scaffold (Cappello et al, 2012); thus, our findings that RhoA is activated in Ccm3 conditional mutants could partially explain the migration defects.…”
Section: Discussionmentioning
confidence: 99%